Delivery Order SPE2DB20D3103-SPE2DB25FP1N1

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $4,266.10 and is a firm-fixed-price delivery order, with a completion date of May 30, 2025. The contract is not set aside for any small business program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,387.84 Firm Fixed Price Delivery Order is for the supply of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a period of performance through July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $4,728.70 contract is for the delivery of RUXIENCE 500 MG/50 ML vial medication with an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a $1,944.73 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medical product, with a completion date of January 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, with a firm fixed price ceiling of $4,892.20 and a period of performance through June 11, 2025. This delivery order is not associated with a set-aside program. AmerisourceBergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a ceiling value of $11,348.88 and a period of performance through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen...
This is a $6,359.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RUXIENCE 500 mg/50 ml vials and has an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1N1
    Delivery Order

This is a Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $8,895.73 and a period of performance through June 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical and pharmaceutical products to federal agencies. This delivery order is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/11/25, 10:55 AM